Loading clinical trials...
Loading clinical trials...
A Phase II Trial of Celecoxib Plus Interferon Alpha in Metastatic Renal Cell Carcinoma Patients With 3+ COX-2 Tumor Immunostaining
Conditions
Interventions
celecoxib
recombinant interferon alfa-2b
+6 more
Locations
1
United States
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Start Date
March 1, 2006
Primary Completion Date
September 1, 2010
Completion Date
October 1, 2010
Last Updated
August 7, 2012
NCT06391099
NCT06349642
NCT04473781
NCT07227415
NCT07294859
NCT07190638
Lead Sponsor
Case Comprehensive Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions